Miklos Toth, MD, PhD, Advances Neuropharmacology Through Research on Epigenetics, Environment and Brain Disorders
Weill Cornell Medicine professor and distinguished neuropharmacologist Miklos Toth, MD, PhD, has built a decades-long research career investigating how genes, environmental experiences and epigenetic mechanisms shape brain function, behavior and vulnerability to neuropsychiatric disorders.
NEW YORK, N.Y.: Dynamo Times highlights Miklos Toth, MD, PhD, a distinguished neuropharmacologist and professor at Weill Cornell Medicine whose research examines how the nervous system responds to environmental challenges and how those experiences can influence gene regulation, brain function and behavior.
Dr. Toth has spent more than three decades at Weill Cornell Medicine developing a body of research at the intersection of pharmacology, neuroscience, genetics, epigenetics and behavioral science. His laboratory studies how experiences such as early-life adversity, social isolation, psychological stress and exposure to drugs can produce molecular changes in neurons. A major objective is understanding when these biological responses help an individual adapt and when they may contribute to neuropsychiatric disorders.
His work has explored anxiety, depression, drug-related behavior and mechanisms of non-genetic inheritance, with the broader goal of identifying biological pathways that could eventually lead to more targeted approaches to treatment. In 2024, Weill Cornell Medicine appointed Dr. Toth the inaugural Arleen B. Rifkind, MD Professor in the Department of Pharmacology, an endowed professorship recognizing an outstanding faculty member engaged in basic research in pharmacology or toxicology.
A central theme of Dr. Toth's work is epigenetics. Genes contain biological instructions, but the activity of those genes can be regulated in complex ways. Epigenetic mechanisms can influence whether particular genes become more or less active without changing the underlying DNA sequence itself. Dr. Toth's laboratory studies small regions across the neuronal epigenome that respond to environmental challenges by changing gene-regulatory activity. These changes can influence transcription, neuronal function and ultimately behavior, providing a framework for examining how life experiences become connected to lasting biological responses in the brain.
The human nervous system is continually responding to the environment. Dr. Toth's research program examines experiences including fetal and childhood adversity, social isolation, psychological trauma and exposure to drugs. His laboratory uses experimental models to investigate how these environmental challenges influence epigenetic and transcriptional processes in neurons. The objective is to connect events occurring outside the body with measurable molecular changes inside the nervous system, understanding that pathway may help researchers determine why some biological responses promote adaptation while others become associated with maladaptive behavior.
Dr. Toth has contributed extensively to research involving serotonin and anxiety-related behavior. Among his published work is research examining the 5-HT1A serotonin receptor, an important component of serotonin signaling. Experimental models involving this receptor have helped scientists investigate biological mechanisms associated with anxiety. Dr. Toth's research has also explored how maternal biological factors can influence emotional and physical development in offspring, contributing to a broader research direction involving the interaction among genetics, developmental environment and later behavior.
Dr. Toth's research has also investigated mechanisms through which biological influences may be transmitted without changes to the DNA sequence itself. His scholarly work on non-genetic inheritance examines how parental and environmental factors may influence development and behavior in subsequent generations. This field raises important scientific questions about how biological information can be carried through developmental processes and expands the traditional framework researchers use when studying vulnerability to psychiatric and behavioral disorders.
Dr. Toth has also examined how medications and drugs of abuse can affect epigenetic processes in the brain. In a major review on epigenetic neuropharmacology, he discussed how different drug classes can alter gene regulation and behavior through their effects on the epigenome. Changes in DNA methylation, histone regulation and gene expression can potentially contribute to longer-term effects on neural function, understanding these processes may provide additional insight into both therapeutic medications and substances associated with addiction.
Recent research connected to his laboratory has examined changes in DNA methylation and gene activity associated with cocaine reward-related learning. Work in this area seeks to understand how drug experiences become biologically encoded in brain circuits involved in memory and behavior. A clearer understanding of these processes could eventually help researchers identify new pharmacological targets.
Dr. Toth earned his MD and PhD in Hungary before continuing his scientific development internationally. He was an Alexander von Humboldt Fellow in Germany from 1988 to 1990, then became an Associate of the Howard Hughes Medical Institute at Princeton University from 1990 to 1992. He joined the Department of Pharmacology at Weill Cornell Medicine as an assistant professor in 1993 and has remained there since, building a research program that spans pharmacology, neuroscience and behavioral science.
Dr. Toth's research career has received support and recognition from multiple scientific organizations. His distinctions include NARSAD Investigator recognition in 1996 and 2003, FRAXA Foundation Investigator recognition in 2003 and 2004, and EUREKA: Exceptional, Unconventional Research Enabling Knowledge Acceleration, grant support in 2009 and 2013. In 2024, he became the inaugural Arleen B. Rifkind, MD Professor in the Department of Pharmacology at Weill Cornell Medicine, an endowed position established in memory of a longtime faculty member to support outstanding basic research in pharmacology or toxicology.
As a professor at Weill Cornell Medicine, Dr. Toth participates in an environment where research laboratories also serve as training grounds for developing scientists. His affiliations span the Pharmacology and Neuroscience programs. Students and research trainees working in this environment gain exposure to experimental design, molecular neuroscience, behavioral research and the process of translating scientific questions into testable hypotheses.
Dynamo Times recognizes Miklos Toth, MD, PhD, for his contributions to neuropharmacology, neuroscience and epigenetic research and for a career dedicated to understanding the molecular connections among environment, brain function and behavior.
About Weill Cornell Medicine
Miklos Toth, MD, PhD, is the Arleen B. Rifkind, MD Professor in the Department of Pharmacology at Weill Cornell Medicine and a distinguished neuropharmacologist affiliated with the institution's pharmacology and neuroscience programs. He earned his MD and PhD in Hungary, served as an Alexander von Humboldt Fellow in Germany and was an Associate of the Howard Hughes Medical Institute at Princeton University before joining Weill Cornell Medicine in 1993. The Toth Laboratory studies environmental and epigenetic influences on the nervous system, including mechanisms associated with adversity, social experience, drug exposure, anxiety, depression and drug-related behavior.